Merck & Company, Inc.
Latest News
-
Since Gaining European Authority Approval for Victrelis in July and Incivo in September, Protease Inhibitor Share Has Penetrated Nearly One-Third of the Genotype 1 Market and is Anticipated to Significantly Increase Over the Next Six Months
— May 21 2012 12:34 PM from Business Wire -
FDA Approves New Labeling for ISENTRESS® (raltegravir) to Include 156-Week Data Demonstrating Long-Term Efficacy, Safety and Tolerability with ISENTRESS in Combination Therapy in Previously Untreated Adult Patients Infected with HIV-1
— May 21 2012 12:34 PM from Business Wire -
Disneyland Paris Takes Top Prize At Eleventh Annual Creative Business Idea Awards
— May 21 2012 12:08 PM from PR Newswire -
Discovery Laboratories: A Hidden Gem In Biotech
— May 21 2012 11:43 AM from Seeking Alpha -
NewsGator taps surging European demand for enterprise social with steep 76%-plus year-over-year growth
— May 21 2012 8:12 AM from PR Newswire
